BENGALURU, India--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon ® Family of intraocular ...
New Alcon Innovations in Intraocular Lenses, Digital Health Solutions to be Showcased at the AAO 2020 Virtual Annual Meeting Pivotal data on the novel AcrySof® IQ Vivity® IOL to be presented ahead of ...
Alcon noted that Clareon offers a sharp, crisp vision with a proprietary edge designed to help reduce glare and posterior capsular opacification. Its STABLEFORCE Haptics provides superior axial and ...
Alcon is introducing multifocal and multifocal toric ultraviolet-absorbing IOLs to the AcrySof portfolio, as well as the AcrySof UV-absorbing monofocal IOL with the UltraSert pre-loaded delivery ...
Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...
GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...
Alcon Canada Introduces the Clareon IOL with the AutonoMe Preloaded Intraocular Lens Delivery System
TORONTO, Feb. 1, 2021 /CNW/ - Alcon, the global leader in eye care, is pleased to announce a nationwide launch of the Clareon ® intraocular lens (IOL) with the AutonoMe ® delivery system in Canada.
Please provide your email address to receive an email when new articles are posted on . Alcon’s AcrySof IQ monofocal IOL and AcrySof IQ PanOptix trifocal IOL both had positive results in studies ...
Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...
Clareon PanOptix, which delivers exceptional clarity and offers spectacle independence across all distances with a patient satisfaction rate of 99.2%31-34; PanOptix® Trifocal IOL, implanted over 2.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results